Allspring Global Investments Holdings, LLC Mannkind Corp Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$3.91 - $5.45 $103,466 - $144,217	26,462 New	26,462 $109,000
Q2 2023 Jul 18, 2023	BUY	$3.72 - $4.79 $60,319 - $77,669	16,215 Added 88.81%	34,473 $140,000
Q1 2023 Apr 13, 2023	SELL	$3.95 - $5.63 $6,071 - $8,653	-1,537 Reduced 7.76%	18,258 $74,000
Q4 2022 Jan 23, 2023	SELL	$3.02 - $5.37 $1,307 - $2,325	-433 Reduced 2.14%	19,795 $0
Q3 2022 Oct 26, 2022	BUY	$2.99 - $4.35 $14,854 - $21,610	4,968 Added 32.56%	20,228 $62,000
Q2 2022 Jul 25, 2022	SELL	$2.67 - $4.77 $257,745 - $460,467	-96,534 Reduced 86.35%	15,260 $58,000
Q1 2022 May 02, 2022	BUY	$2.62 - $4.45 $10,660 - $18,107	4,069 Added 3.78%	111,794 $411,000
Q4 2021 Jan 28, 2022	BUY	$4.05 - $5.37 $436,286 - $578,483	107,725 New	107,725 $470,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account